Palisade Bio Stock Price Prediction
| PALI Stock | USD 4.16 0.04 0.97% |
Oversold Vs Overbought
46
Oversold | Overbought |
Palisade Bio stock price prediction is an act of determining the future value of Palisade Bio shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Palisade Bio's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Palisade Bio and does not consider all of the tangible or intangible factors available from Palisade Bio's fundamental data. We analyze noise-free headlines and recent hype associated with Palisade Bio, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Palisade Bio's stock price prediction:EPS Estimate Next Quarter (0.32) | EPS Estimate Current Year (14.32) | EPS Estimate Next Year (11.85) | Wall Street Target Price 33.75 | EPS Estimate Current Quarter (0.34) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Palisade Bio based on different types of headlines from major news networks to social media. The Palisade stock price prediction module provides an analysis of price elasticity to changes in media outlook on Palisade Bio over a specific investment horizon. Using Palisade Bio hype-based prediction, you can estimate the value of Palisade Bio from the perspective of Palisade Bio response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Palisade Bio. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Palisade Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Palisade because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Palisade Bio after-hype prediction price | USD 6.29 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Palisade |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Palisade Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Palisade Bio After-Hype Price Prediction Density Analysis
As far as predicting the price of Palisade Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Palisade Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Palisade Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Palisade Bio Estimiated After-Hype Price Volatility
In the context of predicting Palisade Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Palisade Bio's historical news coverage. Palisade Bio's after-hype downside and upside margins for the prediction period are 0.31 and 18.89, respectively. We have considered Palisade Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Palisade Bio is very risky at this time. Analysis and calculation of next after-hype price of Palisade Bio is based on 3 months time horizon.
Palisade Bio Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Palisade Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Palisade Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Palisade Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.42 | 12.60 | 2.26 | 0.05 | 9 Events / Month | 8 Events / Month | In about 9 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.16 | 6.29 | 51.13 |
|
Palisade Bio Hype Timeline
Palisade Bio is at this time traded for 4.16. The entity has historical hype elasticity of 2.26, and average elasticity to hype of competition of 0.05. Palisade is expected to increase in value after the next headline, with the price projected to jump to 6.28687323943662 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 51.13%, whereas the daily expected return is at this time at -0.42%. The volatility of related hype on Palisade Bio is about 10573.43%, with the expected price after the next announcement by competition of 4.21. The company currently holds 158 K in liabilities with Debt to Equity (D/E) ratio of 0.23, which may suggest the company is not taking enough advantage from borrowing. Palisade Bio has a current ratio of 2.54, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Palisade Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Palisade Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Palisade Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Palisade to invest in growth at high rates of return. When we think about Palisade Bio's use of debt, we should always consider it together with cash and equity.Given the investment horizon of 90 days the next expected press release will be in about 9 days. Check out Palisade Bio Basic Forecasting Models to cross-verify your projections.Palisade Bio Related Hype Analysis
Having access to credible news sources related to Palisade Bio's direct competition is more important than ever and may enhance your ability to predict Palisade Bio's future price movements. Getting to know how Palisade Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Palisade Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ZURA | Zura Bio Limited | (0.08) | 6 per month | 0.00 | (0.03) | 10.89 | (9.32) | 42.14 | |
| CYTO | Altamira Therapeutics | (0.03) | 8 per month | 0.00 | (0.09) | 7.73 | (9.19) | 47.75 | |
| IMMX | Immix Biopharma | (0.05) | 7 per month | 0.00 | (0.19) | 8.22 | (9.46) | 23.82 | |
| ENVB | Enveric Biosciences | (0.12) | 9 per month | 5.51 | 0.01 | 15.29 | (11.00) | 86.10 | |
| EFTR | Effector Therapeutics | 1.52 | 8 per month | 0.00 | (0.08) | 11.60 | (15.14) | 98.22 | |
| VIRI | Virios Therapeutics Llc | (0.02) | 3 per month | 9.05 | 0.00 | 13.16 | (12.50) | 55.89 | |
| NAVB | Navidea Biopharmaceuticals | 0.00 | 0 per month | 6.79 | 0.01 | 20.00 | (12.50) | 61.04 | |
| ZVSA | ZyVersa Therapeutics | 0.08 | 10 per month | 0.00 | (0.03) | 10.00 | (9.86) | 45.47 | |
| PHIO | Phio Pharmaceuticals Corp | 0.04 | 8 per month | 6.05 | 0 | 10.84 | (10.45) | 38.44 | |
| NBY | NovaBay Pharmaceuticals | 0.00 | 6 per month | 0.00 | (0.17) | 7.69 | (9.85) | 33.93 | |
| UNCY | Unicycive Therapeutics | 0.12 | 9 per month | 4.38 | 0.06 | 12.33 | (6.67) | 29.80 | |
| APGN | Apexigen | (0.03) | 3 per month | 0.00 | (0.11) | 6.52 | (6.82) | 19.80 |
Palisade Bio Additional Predictive Modules
Most predictive techniques to examine Palisade price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Palisade using various technical indicators. When you analyze Palisade charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Palisade Bio Predictive Indicators
The successful prediction of Palisade Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Palisade Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Palisade Bio based on analysis of Palisade Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Palisade Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Palisade Bio's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.007332 | 0.006518 | Price To Sales Ratio | 975.13 | 926.37 |
Story Coverage note for Palisade Bio
The number of cover stories for Palisade Bio depends on current market conditions and Palisade Bio's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Palisade Bio is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Palisade Bio's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Palisade Bio Short Properties
Palisade Bio's future price predictability will typically decrease when Palisade Bio's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Palisade Bio often depends not only on the future outlook of the potential Palisade Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Palisade Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.3 M | |
| Shares Float | 836.5 K |
Check out Palisade Bio Basic Forecasting Models to cross-verify your projections. For more detail on how to invest in Palisade Stock please use our How to Invest in Palisade Bio guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Palisade Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Palisade Bio. If investors know Palisade will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Palisade Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.00) | Revenue Per Share 0.548 | Return On Assets (0.54) | Return On Equity (1.03) |
The market value of Palisade Bio is measured differently than its book value, which is the value of Palisade that is recorded on the company's balance sheet. Investors also form their own opinion of Palisade Bio's value that differs from its market value or its book value, called intrinsic value, which is Palisade Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Palisade Bio's market value can be influenced by many factors that don't directly affect Palisade Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Palisade Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Palisade Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Palisade Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.